Guru Ownership Trend
Guru Analysis for Rigel Pharmaceuticals, Inc. (RIGL)
Rigel Pharmaceuticals, Inc. (RIGL), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 2 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $17.68 M.
Top institutional holders include Renaissance Technologies (RenTech) and Cliff Asness.
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $8.38 M net outflow during the quarter.
On the selling side, Renaissance Technologies (RenTech) reduced exposure by 37.2%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Rigel Pharmaceuticals, Inc. (RIGL)
Major holders include Renaissance Technologies (RenTech) ($9.15 M), Cliff Asness ($2.46 M). According to the latest reported data, 2 tracked investment managers collectively hold approximately 429,449 shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $8.38 M, with 0 managers increasing positions and 4 managers reducing holdings.
During the most recent reporting period, 2 managers trimmed their positions, while 2 fully exited RIGL. The total reported sell value was $8.38 M.
No tracked managers opened new positions or increased their holdings in RIGL during the most recent reporting period.